GlobeNewsWire
15 Jul 2026, 11:45 UTC · 12w ago
Verdict
Headline takes no side. We score PROF +0.80 across three claims — strongly bullish.
+0.80strongly bullish
More positive than 88% of ticker scores this week
What the story claims
3 claims · scored −1 bearish … +1 bullish
Profound Medical's TULSA Procedure has been selected as one of only eight companies to be spotlighted during the Society of Incisionless Surgery (SIS) plenary session at SRS2026.
More positive than 79% of claims this week
Profound Medical's management will participate in an investor session on July 22, 2026, moderated by analysts from Stifel Financial and Wells Fargo.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Search tags
More positive than 66% of claims this week
The TULSA Procedure's CPT Category 1 codes became effective in January 2025, facilitating reimbursement.
More positive than 66% of claims this week
Which stocks this story touches
More positive than 88% of ticker scores this week
The company's TULSA procedure will be highlighted in multiple presentations and selected as one of only eight companies spotlighted at a major medical conference.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Zacks Investment Research
1h ago
−1.5%
Price is moving against the score
$6.99 vs $7.10 close before publication (Jul 14) · not market-adjusted
PROF chart →
